SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Cytrx Corp. – ‘10-K’ for 12/31/20 – ‘EX-10.8’

On:  Wednesday, 3/24/21, at 6:12am ET   ·   For:  12/31/20   ·   Accession #:  1493152-21-6668   ·   File #:  0-15327

Previous ‘10-K’:  ‘10-K’ on 3/27/20 for 12/31/19   ·   Next:  ‘10-K/A’ on 7/13/21 for 12/31/20   ·   Latest:  ‘10-K’ on 3/27/24 for 12/31/23   ·   25 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/24/21  Cytrx Corp.                       10-K       12/31/20   68:8.1M                                   M2 Compliance LLC/FA

Annual Report   —   Form 10-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    566K 
 2: EX-10.3.2   Material Contract                                   HTML     26K 
 3: EX-10.8     Material Contract                                   HTML     45K 
 4: EX-23.1     Consent of Expert or Counsel                        HTML     20K 
 5: EX-31.1     Certification -- §302 - SOA'02                      HTML     23K 
 6: EX-31.2     Certification -- §302 - SOA'02                      HTML     23K 
 7: EX-32.1     Certification -- §906 - SOA'02                      HTML     21K 
 8: EX-32.2     Certification -- §906 - SOA'02                      HTML     21K 
15: R1          Document and Entity Information                     HTML     54K 
16: R2          Consolidated Balance Sheets                         HTML     85K 
17: R3          Consolidated Balance Sheets (Parenthetical)         HTML     37K 
18: R4          Consolidated Statements of Operations               HTML     81K 
19: R5          Consolidated Statements of Stockholders' Equity     HTML     45K 
20: R6          Consolidated Statements of Cash Flows               HTML     98K 
21: R7          Nature of Business                                  HTML     37K 
22: R8          Summary of Significant Accounting Policies          HTML     38K 
23: R9          Discontinued Operations                             HTML     26K 
24: R10         Foreign Currency Remeasurement                      HTML     23K 
25: R11         Equipment and Furnishings                           HTML     25K 
26: R12         Accrued Expenses and Other Current Liabilities      HTML     25K 
27: R13         Leases                                              HTML     30K 
28: R14         Stock Compensation                                  HTML     76K 
29: R15         Stockholder Protection Rights Plan                  HTML     35K 
30: R16         Income Taxes                                        HTML     41K 
31: R17         Commitments and Contingencies                       HTML     33K 
32: R18         Summary of Significant Accounting Policies          HTML     73K 
                (Policies)                                                       
33: R19         Summary of Significant Accounting Policies          HTML     24K 
                (Tables)                                                         
34: R20         Discontinued Operations (Tables)                    HTML     28K 
35: R21         Equipment and Furnishings (Tables)                  HTML     24K 
36: R22         Accrued Expenses and Other Current Liabilities      HTML     25K 
                (Tables)                                                         
37: R23         Leases (Tables)                                     HTML     31K 
38: R24         Stock Compensation (Tables)                         HTML     84K 
39: R25         Income Taxes (Tables)                               HTML     37K 
40: R26         Commitments and Contingencies (Tables)              HTML     24K 
41: R27         Nature of Business (Details Narrative)              HTML     50K 
42: R28         Summary of Significant Accounting Policies          HTML     34K 
                (Details Narrative)                                              
43: R29         Summary of Significant Accounting Policies -        HTML     26K 
                Schedule of Fair Value Measurements by Level for                 
                Assets and Liabilities Measured at Fair Value on a               
                Recurring Basis (Details)                                        
44: R30         Discontinued Operations (Details Narrative)         HTML     27K 
45: R31         Discontinued Operations - Schedule of Discontinued  HTML     35K 
                Operations (Details)                                             
46: R32         Foreign Currency Remeasurement (Details Narrative)  HTML     22K 
47: R33         Equipment and Furnishings (Details Narrative)       HTML     22K 
48: R34         Equipment and Furnishings - Schedule of Equipment   HTML     27K 
                and Furnishings (Details)                                        
49: R35         Accrued Expenses and Other Current Liabilities -    HTML     34K 
                Schedule of Accrued Expenses and Other Current                   
                Liabilities (Details)                                            
50: R36         Leases (Details Narrative)                          HTML     37K 
51: R37         Leases - Schedule of Future Minimum Lease Payments  HTML     39K 
                (Details)                                                        
52: R38         Leases - Schedule of Rent Expense and Supplemental  HTML     29K 
                Cash Flow Information Related to Leases (Details)                
53: R39         Stock Compensation (Details Narrative)              HTML     68K 
54: R40         Stock Compensation - Schedule of Share-based        HTML     32K 
                Payment Award, Fair Value of the Stock Options                   
                Granted, Assumptions (Details)                                   
55: R41         Stock Compensation - Schedule of Stock-based        HTML     28K 
                Compensation Expense (Details)                                   
56: R42         Stock Compensation - Schedule of Stock Options      HTML     63K 
                Activity (Details)                                               
57: R43         Stock Compensation - Schedule of Ranges of Stock    HTML     58K 
                Options (Details)                                                
58: R44         Stock Compensation - Schedule of Warrants Activity  HTML     49K 
                and Related Information (Details)                                
59: R45         Stock Compensation- Schedule of Warrants (Details)  HTML     39K 
60: R46         Stockholder Protection Rights Plan (Details         HTML     34K 
                Narrative)                                                       
61: R47         Income Taxes (Details Narrative)                    HTML     43K 
62: R48         Income Taxes - Schedule of Deferred Tax Assets and  HTML     38K 
                Liabilities (Details)                                            
63: R49         Income Taxes - Schedule of Effective Income Tax     HTML     51K 
                Rate Reconciliation (Details)                                    
64: R50         Commitments and Contingencies (Details Narrative)   HTML     27K 
65: R51         Commitments and Contingencies - Schedule of         HTML     35K 
                Current Contractual Obligations (Details)                        
67: XML         IDEA XML File -- Filing Summary                      XML    115K 
66: EXCEL       IDEA Workbook of Financial Reports                  XLSX     73K 
 9: EX-101.INS  XBRL Instance -- cytr-20201231                       XML    883K 
11: EX-101.CAL  XBRL Calculations -- cytr-20201231_cal               XML    174K 
12: EX-101.DEF  XBRL Definitions -- cytr-20201231_def                XML    389K 
13: EX-101.LAB  XBRL Labels -- cytr-20201231_lab                     XML    822K 
14: EX-101.PRE  XBRL Presentations -- cytr-20201231_pre              XML    613K 
10: EX-101.SCH  XBRL Schema -- cytr-20201231                         XSD    133K 
68: ZIP         XBRL Zipped Folder -- 0001493152-21-006668-xbrl      Zip    105K 


‘EX-10.8’   —   Material Contract


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 

Exhibit 10.8

 

EMPLOYMENT AGREEMENT

 

This Employment Agreement (this “Agreement”) is made and entered into this 5th day of January, 2021, with an effective date of January 1, 2021 (the “Effective Date”) by and between CytRx Corporation, a Delaware corporation (“Employer”), and John Caloz, an individual and resident of the State of California (“Employee”).

 

WHEREAS, Employer desires to continue to employ Employee, and Employee is willing to continue to be employed by Employer, on the terms set forth in this Agreement.

 

NOW, THEREFORE, upon the above premises, and in consideration of the mutual covenants and agreements hereinafter contained, the parties hereto agree as follows.

 

1. Employment. Effective as of the Effective Date, Employer shall continue to employ Employee, and Employee shall serve, as Employer’s Chief Financial Officer on the terms set forth herein.

 

2. Duties; Place of Employment. Employee shall perform in a professional and business-like manner, and to the best of his ability, the duties described on Schedule 1 to this Agreement and such other duties as are assigned to him from time to time by Employer’s Chairman of the Board and Chief Executive Officer. Employee understands and agrees that his duties, title and authority may be changed from time to time in the discretion of Employer’s Chairman of the Board and Chief Executive Officer. Employee’s services hereunder shall be rendered at Employer’s principal executive office, except for travel when and as required in the performance of Employee’s duties hereunder. Notwithstanding the foregoing, Employer understands and agrees that Employee shall be entitled to render his services hereunder from his home when necessary and as agreed with his supervisor.

 

3. Time and Efforts. Employee shall devote all of his business time, efforts, attention and energies to Employer’s business and to discharge his duties hereunder.

 

4. Term. The term (the “Term”) of Employee’s employment hereunder shall commence on the Effective Date and shall expire on December 31, 2021 unless sooner terminated in accordance with Section 6. Neither Employer nor Employee shall have any obligation to extend or renew this Agreement. In the event that Employee’s employment has not theretofore been terminated and Employer has not offered to extend or renew Employee’s employment under this Agreement, upon expiration of the Term Employer shall continue to pay Employee his salary as provided for in Section 5.1 during the period commencing on the final date of the Term and ending on (a) June 30, 2022 or (b) the date of Employee’s re-employment with another employer, whichever is earlier; provided that, as a condition to Employer’s obligations under this sentence, Employee shall have executed and delivered to Employer a General Release of All Claims in the form attached hereto as Exhibit A. Employee shall notify Employer immediately in the event Employee accepts such employment with another employer.

 

 C: 
 

 

 

5. Compensation. As the total consideration for Employee’s services rendered hereunder, Employer shall pay or provide Employee the following compensation and benefits:

 

5.1. Salary. Employee shall be entitled to receive an annual salary of Four Hundred Thousand Dollars ($400,000), payable in accordance with Employer’s normal payroll policies and procedures.

 

5.2. Discretionary Bonus. Employee also may be eligible for a bonus from time to time for his services during the Term. Employee’s eligibility to receive a bonus, any determination to award Employee such a bonus and, if awarded, the amount thereof shall be in Employer’s sole discretion.

 

5.3. Expense Reimbursement. Employer shall reimburse Employee for reasonable and necessary business expenses incurred by Employee in connection with the performance of Employee’s duties in accordance with Employer’s usual practices and policies in effect from time to time.

 

5.4. Vacation. Employee shall continue to accrue vacation days without loss of compensation in accordance with Employer’s usual policies applicable to all employees at a rate of four weeks’ vacation time for each 12-month period during the Term.

 

5.5. Employee Benefits. Employee shall be eligible to participate in all employee benefit plans and programs, fringe benefits and perquisites as in effect generally with respect to other senior officers of Employer.

 

5.6. Payroll Taxes. Employer shall have the right to deduct from the compensation and benefits due to Employee hereunder any and all sums required for social security and withholding taxes and for any other federal, state, or local tax or charge which may be in effect or hereafter enacted or required as a charge on the compensation or benefits of Employee.

 

5.7. Termination. This Agreement may be terminated as set forth in this Section 6.

 

5.8. Termination by Employer for Cause. Employer may terminate Employee’s employment hereunder for “Cause” upon notice to Employee. “Cause” for this purpose shall mean any of the following:

 

(a) Employee’s breach of any material term of this Agreement; provided that the first occasion of any particular breach shall not constitute such Cause unless Employee shall have previously received written notice from Employer stating the nature of such breach and affording Employee at least ten days to correct such breach;

 

 C: 
 

 

 

(b) Employee’s conviction of, or plea of guilty or nolo contendere to, any misdemeanor, felony or other crime of moral turpitude;

 

(c) Employee’s act of fraud or dishonesty injurious to Employer or its reputation;

 

(d) Employee’s continual failure or refusal to perform his material duties as required under this Agreement after written notice from Employer stating the nature of such failure or refusal and affording Employee at least ten days to correct the same;

 

(e) Employee’s act or omission that, in the reasonable determination of Employer’s Board of Directors (or a Committee of the Board), indicates alcohol or drug abuse by Employee; or

 

(f) Employee’s act or personal conduct that, in the judgment of Employer’s Board of Directors (or a Committee of the Board), gives rise to a material risk of liability of Employee or Employer under federal or applicable state law for discrimination, or sexual or other forms of harassment, or other similar liabilities to subordinate employees.

 

Upon termination of Employee’s employment by Employer for Cause, all compensation and benefits to Employee hereunder shall cease and Employee shall be entitled only to payment upon the effective date of termination of any accrued but unpaid salary and unused vacation as provided in Sections 5.1 and 5.5 as of the date of such termination and any unpaid bonus that may have been awarded Employee as provided in Section 5.2 prior to such date.

 

5.9. Termination by Employer without Cause. Employer may also terminate Employee’s employment without Cause upon ten days’ notice to Employee. Upon termination of Employee’s employment by Employer without Cause, all compensation and benefits to Employee hereunder shall cease and Employee shall be entitled to (1) any accrued but unpaid salary and unused vacation as of the date of such termination as required by California law, which shall be due and payable upon the effective date of such termination, (2) any unpaid bonus that may have been awarded to Employee under Section 5.2 prior to such date, which shall be due and payable in accordance with Employer’s normal payroll practices or as otherwise required by California law, (3) all of Employee’s vested stock options and other equity awards as of the date of termination of Employee’s employment shall remain exercisable for their full term, (4) retain and have full ownership of all electronic devices provided to Employee (including, without limitation, a computer, telephone, tablet and printer), provided that all Employer confidential information shall be deleted by Employer from such devices before releasing them to Employee, (5) an amount, which shall be due and payable within ten days following the effective date of such termination, equal to six months’ salary as provided in Section 5.1., provided, that if such termination occurs following a Change of Control (as hereinafter defined), then the amount described in this clause (5) shall be equal to 12 months’ salary as provided in Section 5.1, any amount due under Section 5.2, and (6) continued participation, at Employer’s cost and expense, of Employee and his dependents for a period of six months following such termination (12 months if such termination occurs following a Change of Control) in any Employer-sponsored group benefit plans in which Employee was participating as of the date of termination. Employee’s right to the compensation and benefits provided for in clauses (5) and (6) of this Section 6.2 shall be conditioned upon Employee having executed and delivered to Employer a General Release of All Claims in the form attached hereto as Exhibit A. For purposes of this Section 6.2, a “Change of Control” shall have the meaning ascribed to the term “Corporate Transaction” in Employer’s 2019 Stock Incentive Plan, as such Plan may be amended from time to time.

 

 C: 
 

 

 

6.3 Death or Disability. In the event of Employee’s death or “Disability” (as defined below) during the Term, the Employee’s employment shall automatically cease and terminate as of the date of Employee’s death or the effective date of Employer’s written notice to Employee of its decision to terminate his employment by reason of his Disability, as the case may be, and Employee or his heirs or personal representative shall be entitled to the same payments and benefits, at the same times, as described in Section 6.2 for a termination of employment by Employer without Cause and all of Employee’s stock options and any other equity awards based on Employer securities held by Employee at the time of his death or Disability shall immediately vest in full and shall remain exercisable thereafter for their full term. In addition, Employee or his heirs or personal representative shall be entitled to retain and have full ownership of all electronic devices provided to Employee (including, without limitation, a computer, telephone and tablet); provided that all Employer confidential information shall be deleted by Employer from such devices before releasing them to Employee or such heirs or personal representatives. Notwithstanding the foregoing or any provision of Section 6.2, Employer’s obligation to pay Employee the salary called for in Section 6.2 for the Severance Period following termination of his employment by reason of his Disability shall be subject to offset and shall be reduced by any and all amounts paid to Employee under any disability insurance policy paid or provided for by Employer as provided in Section 5.6 or otherwise. Employee’s “Disability” shall have the meaning ascribed to such term in any policy of disability insurance maintained by Employer (or by Employee, as the case may be) with respect to Employee or, if no such policy is then in effect, shall mean Employee’s inability to fully perform his duties hereunder for any period of at least 75 consecutive days or for a total of 90 days, whether or not consecutive.

 

6. Confidentiality. While this Agreement is in effect and for a period of five years thereafter, Employee shall hold and keep secret and confidential all “trade secrets” (within the meaning of applicable law) and other confidential or proprietary information of Employer and shall use such information only in the course of performing Employee’s duties hereunder; provided, however, that with respect to trade secrets, Employee shall hold and keep secret and confidential such trade secrets for so long as they remain trade secrets under applicable law. Employee shall maintain in trust all such trade secrets or other confidential or proprietary information, as Employer’s property, including, but not limited to, all documents concerning Employer’s business, including Employee’s work papers, telephone directories, customer information and notes, and any and all copies thereof in Employee’s possession or under Employee’s control. Upon the expiration or earlier termination of Employee’s employment with Employer, or upon request by Employer, Employee shall deliver to Employer all such documents belonging to Employer, including any and all copies in Employee’s possession or under Employee’s control.

 

 C: 
 

 

 

7. Equitable Remedies; Injunctive Relief. Employee hereby acknowledges and agrees that monetary damages are inadequate to fully compensate Employer for the damages that would result from a breach or threatened breach of Section 7 of this Agreement and, accordingly, that Employer shall be entitled to equitable remedies, including, without limitation, specific performance, temporary restraining orders, and preliminary injunctions and permanent injunctions, to enforce such Section without the necessity of proving actual damages in connection therewith. This provision shall not, however, diminish Employer’s right to claim and recover damages or enforce any other of its legal or equitable rights or defenses.

 

8. Indemnification; Insurance. Employer and Employee acknowledge that, as the Chief Financial Officer of the Employer, Employee shall be a corporate officer of Employer and, as such, Employee shall be entitled to indemnification to the full extent provided by Employer to its officers, directors and agents under the Employer’s Certificate of Incorporation and Bylaws as in effect as of the date of this Agreement. Employer shall maintain Employee as an additional insured under its current policy of directors and officers liability insurance and shall use commercially reasonable efforts to continue to insure Employee thereunder, or under any replacement policies in effect from time to time, during the Term.

 

9. Severable Provisions. The provisions of this Agreement are severable and if any one or more provisions is determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions, and any partially unenforceable provisions to the extent enforceable, shall nevertheless be binding and enforceable.

 

10. Successors and Assigns. This Agreement shall inure to the benefit of and shall be binding upon Employer, its successors and assigns and Employee and his heirs and representatives; provided, that this Agreement may be assigned by Employer to a successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business or assets of Employer.

 

11. Entire Agreement. This Agreement contains the entire agreement of the parties relating to the subject matter hereof, and the parties hereto have made no agreements, representations or warranties relating to the subject matter of this Agreement that are not set forth otherwise herein. This Agreement supersedes any and all prior or contemporaneous agreements, written or oral, between Employee and Employer relating to the subject matter hereof. Any such prior or contemporaneous agreements are hereby terminated and of no further effect, and Employee, by the execution hereof, agrees that any compensation provided for under any such agreements is specifically superseded and replaced by the provisions of this Agreement.

 

 C: 
 

 

 

12. Amendment. No modification of this Agreement shall be valid unless made in writing and signed by the parties hereto and unless such writing is made by an executive officer of Employer (other than Employee). The parties hereto agree that in no event shall an oral modification of this Agreement be enforceable or valid.

 

13. Governing Law. This Agreement is and shall be governed and construed in accordance with the laws of the State of California without giving effect to California’s choice-of-law rules.

 

14. Notice. All notices and other communications under this Agreement shall be in writing and mailed, telecopied (in case of notice to Employer only) or delivered by hand or by a nationally recognized courier service guaranteeing overnight delivery to a party at the following address (or to such other address as such party may have specified by notice given to the other party pursuant to this provision):

 

If to Employer:

 

CytRx Corporation

11726 San Vicente Boulevard, Suite 650

Los Angeles, California 90049

Facsimile: (310) 826-5529

Attention: Chief Executive Officer

 

If to Employee:

 

John Caloz

9901 Washington Blvd, Ste 512

Culver City, California 90232

 

15. Survival. Sections 7 through 16, 18 and 19 shall survive the expiration or termination of this Agreement.

 

16. Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed to be an original and all of which together shall be deemed to be one and the same agreement. A counterpart executed and transmitted by facsimile shall have the same force and effect as an originally executed counterpart.

 

17. Attorney’s Fees. In any action or proceeding to construe or enforce any provision of this Agreement the prevailing party shall be entitled to recover its or his reasonable attorneys’ fees and other costs of suit (up to a maximum of $15,000) in addition to any other recoveries.

 

18. No Interpretation of Ambiguities Against Drafting Party. This Agreement has been negotiated at arm’s length between persons knowledgeable in the matters dealt with herein. In addition, each party has been represented by experienced and knowledgeable legal counsel. Accordingly, the parties agree that any rule of law, including, but not limited to, California Civil Code Section 1654 or any other statutes, legal decisions, or common law principles of similar effect, that would require interpretation of any ambiguities in this Agreement against the party that has drafted it, is of no application and is hereby expressly waived. The provisions of this Agreement shall be interpreted in a reasonable manner to effect the intentions of the parties hereto.

 

[Signature Page Follows]

 

 C: 
 

 

 

IN WITNESS WHEREOF, this Agreement is executed as of the day and year first above written.

 

  “EMPLOYER”
   
  CytRx Corporation
     
  By: /s/ Steven A. Kriegsman 
    Steven A. Kriegsman
    Chairman of the Board and Chief Executive Officer
     
  “EMPLOYEE”
     
  /s/ John Caloz
  John Caloz

 

 C: 
 

 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
6/30/22
12/31/2110-K
Filed on:3/24/21
1/1/21
For Period end:12/31/2010-K/A
 List all Filings 


10 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/27/24  LadRx Corp.                       10-K       12/31/23   67:19M                                    M2 Compliance LLC/FA
 4/14/23  LadRx Corp.                       S-1                   66:6M                                     M2 Compliance LLC/FA
 3/20/23  LadRx Corp.                       10-K       12/31/22   72:6.2M                                   M2 Compliance LLC/FA
 3/23/22  LadRx Corp.                       S-1/A                  3:458K                                   M2 Compliance LLC/FA
 3/23/22  LadRx Corp.                       10-K       12/31/21   72:5.8M                                   M2 Compliance LLC/FA
 8/04/21  LadRx Corp.                       S-1                    3:453K                                   M2 Compliance LLC/FA
 7/15/21  LadRx Corp.                       424B5                  1:344K                                   M2 Compliance LLC/FA
 7/13/21  LadRx Corp.                       10-K/A     12/31/20    4:270K                                   M2 Compliance LLC/FA
 5/14/21  LadRx Corp.                       S-3/A                  3:316K                                   M2 Compliance LLC/FA
 4/22/21  LadRx Corp.                       S-3                    2:280K                                   M2 Compliance LLC/FA


15 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/17/20  LadRx Corp.                       8-K:1,3,5,911/12/20    4:721K                                   M2 Compliance LLC/FA
12/19/19  LadRx Corp.                       8-K:1,3,5,912/13/19    8:557K                                   M2 Compliance LLC/FA
11/15/19  LadRx Corp.                       8-K:5,9    11/15/19    2:123K                                   M2 Compliance LLC/FA
 3/29/19  LadRx Corp.                       10-K       12/31/18   82:6M                                     M2 Compliance LLC/FA
11/01/17  LadRx Corp.                       8-K:5,9    10/27/17    4:56K
 8/01/17  LadRx Corp.                       8-K:1,2,3,8 7/27/17    8:879K
 5/20/16  LadRx Corp.                       DEF 14A     5/18/16    1:802K
 3/11/16  LadRx Corp.                       10-K       12/31/15   82:7.9M
 3/17/14  LadRx Corp.                       8-K:1,9     3/14/14    2:42K
 5/15/12  Cytrx Corp.                       8-K:5,8,9   5/14/12    3:61K
 3/13/12  Cytrx Corp.                       10-K       12/31/11   50:5.7M
 8/09/11  Cytrx Corp.                       10-Q        6/30/11   33:2.4M
 6/09/08  Cytrx Corp.                       8-K:1,8,9   6/06/08    6:605K                                   Bowne - Bde
 5/14/04  Cytrx Corp.                       10-K       12/31/03   25:1.7M                                   Bowne of Century City/FA
12/21/01  Cytrx Corp.                       8-K:5,7    12/19/01    2:58K                                    Donnelley Fin’l S… 10/FA
Top
Filing Submission 0001493152-21-006668   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., May 2, 3:54:57.3pm ET